Pathophysiology, Genetics & Classification

QuestionAnswer
1. What is the fundamental cellular pathophysiology driving severe acute asthma exacerbations?An acute, reversible, IgE-mediated type 1 hypersensitivity reaction leading to mast cell degranulation, histamine release, cysteinyl leukotriene secretion, acute bronchoconstriction, airway mucosal edema, and luminal mucus plugging.
2. According to GINA clinical phenotyping, what distinguishes episodic viral wheeze from multiple-trigger wheeze in young children?Episodic viral wheeze occurs strictly during discreet viral upper respiratory infections with complete symptom-free intervals, whereas multiple-trigger wheeze occurs with viral infections alongside non-viral triggers like exercise, cold air, and allergen exposure.
3. What are the major and minor criteria comprising the Modified Asthma Predictive Index (mAPI) for children under 3 years with recurrent wheeze?Major criteria include parental history of physician-diagnosed asthma, physician-diagnosed atopic dermatitis, and allergic sensitization to at least one aeroallergen; minor criteria include allergic sensitization to milk/egg/peanut, wheezing unrelated to colds, and peripheral blood eosinophilia ≥4%.
4. What is the primary molecular genetic inheritance pattern and chromosomal association implicated in childhood asthma?Asthma exhibits a complex polygenic inheritance pattern, with major susceptibility loci mapped to chromosome 5q31-33 (harboring genes for IL-4, IL-5, IL-13, and GM-CSF) and chromosome 17q21 (ORMDL3/GSDMB locus).
5. What immune cell predominantly drives the late-phase asthmatic response through type 2 inflammation?The T-helper 2 (Th2) lymphocyte, alongside group 2 innate lymphoid cells (ILC2s), which secrete cytokines IL-4, IL-5, and IL-13 that drive B-cell IgE class switching and eosinophilic airway infiltration.
6. What structural anatomical airway remodeling changes occur in chronic severe asthma?Subepithelial basement membrane reticular fibrosis, goblet cell hyperplasia and hypertrophy, airway smooth muscle hypertrophy and hyperplasia, and increased mucosal vascularity with microvascular leakage.
7. What physiological mechanism causes prominent nocturnal awakening between 2 AM to 5 AM in severe asthmatic children?A circadian nadir in endogenous cortisol and epinephrine levels combined with physiological nocturnal vagal nerve hyperactivity, leading to increased bronchomotor tone and nocturnal bronchoconstriction.
8. What pathophysiological event leads to the clinical sign of a 'silent chest' during a severe acute asthma attack?Critical airflow limitation where expiratory airflow velocity drops so low that turbulent wheezing sounds can no longer be generated, signaling severe bronchoconstriction, dynamic hyperinflation, and impending respiratory arrest.
9. How does dynamic hyperinflation impact cardiac function and cause pulsus paradoxus in severe asthma?Extreme negative intrapleural pressure swings and air trapping increase right ventricular afterload and impede left ventricular venous return during inspiration, causing an exaggerated drop in systolic blood pressure >10 to 15 mmHg.
10. What is the Pediatric Respiratory Assessment Measure (PRAM) score, and what are its component parameters?A validated 12-point clinical score assessing exacerbation severity using suprasternal retractions, scalene muscle contraction, air entry, wheezing, and oxygen saturation.
11. What anatomical changes characterize acute pulmonary hyperinflation on examination and imaging in severe asthma?Bilateral hyperresonance on percussion with downward displacement of hepatic dullness, and on chest radiograph, hypertranslucency, flattening of the diaphragms, and verticalization of the heart.
12. What is the precise role of the ORMDL3 gene on chromosome 17q21 in asthma pathogenesis?It encodes an endoplasmic reticulum transmembrane protein regulating sphingolipid biosynthesis, calcium homeostasis, and unfolded protein response pathways, which directly modulate airway epithelial inflammation and bronchial hyperresponsiveness.
13. Why does room-air hypoxemia develop during severe acute asthma exacerbations despite adequate total minute ventilation?Severe ventilation-perfusion (V/Q) mismatching caused by uneven regional airway obstruction, leading to alveolar hypoventilation in poorly ventilated lung units alongside increased physiological dead space.
14. What is the GINA-defined pathophysiological mechanism of the Single Maintenance and Reliever Therapy (SMART) approach?Combining an inhaled corticosteroid (budesonide) with a rapid-onset, long-acting beta-2 agonist (formoterol) ensures that every time smooth muscle relaxation is triggered, anti-inflammatory therapy is simultaneously delivered to treat underlying mucosal inflammation.
15. VIVA TRAP: Can a normal or high PaCO2 in a child with severe acute asthma be interpreted as reassuring because the child is not retaining carbon dioxide?NO. A normal or elevated PaCO2 in a severe acute asthma attack is an ominous sign of alveolar hypoventilation, respiratory muscle fatigue, and impending respiratory failure.
16. How do epithelial-derived alarmins (TSLP, IL-25, and IL-33) initiate the type 2 immune cascade in asthma?They are released by damaged airway epithelial cells in response to triggers and activate dendritic cells and group 2 innate lymphoid cells (ILC2s), kickstarting the downstream eosinophilic and IgE-mediated inflammatory cascade.
17. What specific pathological changes account for the immediate bronchodilator response to inhaled short-acting beta-2 agonists?Direct stimulation of beta-2 adrenergic receptors on airway smooth muscle cells activates adenylate cyclase, increases intracellular cAMP, decreases intracellular calcium, and induces rapid smooth muscle relaxation.
18. What is the classification threshold for classifying an acute asthma exacerbation as life-threatening based on clinical parameters?Presence of a silent chest, cyanosis, feeble or absent respiratory effort, exhaustion, altered sensorium, bradycardia, or a peak expiratory flow rate <25 percent of predicted value.

Clinical History & Bedside Evaluation

QuestionAnswer
1. What specific historical pattern of symptom onset and diurnal variation strongly supports a clinical diagnosis of severe asthma over other airway disorders?A history of paroxysmal dry or productive cough, chest tightness, and bilateral wheezing that characteristically worsens in the early morning hours (between 2 AM and 5 AM) and displays complete reversibility following bronchodilator therapy strongly points to asthma.
2. How do you elicit a precise history regarding the chronologic progression and trigger profile during the present illness of an asthmatic child?Inquire systematically about the exact time of onset, whether symptoms were provoked by viral upper respiratory infections, exercise, cold air, emotional laughter, crying, or specific environmental aeroallergens like house dust mites and tobacco smoke.
3. What historical red flags indicate a high-risk phenotype or a history of near-fatal asthma exacerbations requiring prioritization?A past history of intubation and mechanical ventilation, previous Pediatric Intensive Care Unit (PICU) admissions, multiple oral corticosteroid bursts in the past year, and frequent emergency department visits are critical markers of high risk.
4. What specific developmental and perinatal history items should be actively sought when evaluating an infant or young child presenting with wheezing?Inquire about prematurity, low birth weight, neonatal respiratory distress syndrome, history of mechanical ventilation or bronchopulmonary dysplasia, and early-life viral bronchiolitis hospitalizations.
5. What dietary recall elements are essential in exploring food-induced triggers or concurrent atopic manifestations in a pediatric asthma history?Document any documented or suspected IgE-mediated food allergies to cow's milk, eggs, peanuts, or tree nuts, as well as food additives or preservatives like sulfites that can precipitate severe bronchospasm.
6. How should the family pedigree be constructed to screen for hereditary atopic diathesis in a child being evaluated for severe asthma?Inquire specifically about first-degree relatives (parents and siblings) for a documented history of physician-diagnosed asthma, allergic rhinitis, chronic urticaria, or atopic dermatitis.
7. What clinical history features help differentiate severe acute asthma from foreign body aspiration in a toddler?A sudden onset of choking or gagging while eating or playing with small objects without any preceding prodromal upper respiratory infection strongly favors foreign body aspiration over asthma.
8. What historical clues in a young infant presenting with wheezing and recurrent lower respiratory infections point toward cystic fibrosis rather than asthma?A history of meconium ileus, failure to thrive despite a voracious appetite, foul-smelling greasy stools, recurrent greasy diarrhea, and chronic purulent cough point toward cystic fibrosis.
9. What clinical history findings suggest primary immunodeficiency in a child presenting with recurrent wheezing and pulmonary infections?A history of recurrent invasive bacterial infections, persistent oral thrush, chronic diarrhea, poor wound healing, and a family history of early infant deaths due to infection raise suspicion for immunodeficiency.
10. How does a history of gastroesophageal reflux disease (GERD) overlap with or mimic severe acute asthma exacerbations?A history of recurrent nocturnal coughing spells, sour regurgitation, and heartburn, especially if exacerbated after heavy meals or recumbency, suggests micro-aspiration triggering vagally mediated bronchoconstriction.
11. What specific environmental history questions must be asked regarding passive smoke exposure and domestic housing conditions?Inquire about household cigarette or bidi smoking, biomass fuel utilization for cooking, presence of furry pets, upholstered furniture, heavy carpets, and visible indoor mold or dampness.
12. What features in the personal atopic history of a school-aged child support the diagnosis of allergic asthma?A concurrent or antecedent history of infantile eczema, perennial or seasonal allergic rhinitis characterized by sneezing, nasal pruritus, clear rhinorrhea, and nasal obstruction.
13. What historical characteristics help distinguish cardiac wheeze ("cardiac asthma") due to congenital heart disease from primary bronchial asthma?A history of poor weight gain, diaphoresis during feeds, easy fatigability, hepatomegaly, and a previously detected cardiac murmur point toward congestive heart failure.
14. What details should be gathered regarding the patient's baseline daily functioning and asthma control prior to the acute presentation?Assess daytime symptom frequency, limitation of physical activity, nighttime awakenings, and the frequency of rescue short-acting beta-2 agonist use over the preceding 4 weeks.
15. How does a history of medication adherence and inhaler technique assessment impact the clinical evaluation of a severe acute asthma presentation?Inquire directly about missed doses of controller medications, frequency of rescue inhaler refills, and whether the family utilizes a spacer device with correct press-and-breathe coordination.
16. What specific history points help identify vocal cord dysfunction (Vocal Cord Disfunction / Inducible Laryngeal Obstruction) masquerading as severe asthma?A history of inspiratory stridor or tightness referred to the throat rather than the chest, lack of response to bronchodilators, and symptoms abruptly triggered by exercise or stress.
17. VIVA TRAP: Can a completely negative family history of atopy and asthma rule out a diagnosis of bronchial asthma in an older child presenting with acute wheezing?NO. Up to 30-40% of children with bronchial asthma may have no positive family history, as environmental factors, viral infections, and polygenic non-atopic phenotypes play major contributory roles.
18. What chronological age distribution and seasonal patterns characterize the typical presentation of episodic viral wheeze versus multi-trigger asthma?Episodic viral wheeze predominantly occurs in children under 3 years old with clustering during autumn and winter viral seasons, whereas multi-trigger asthma persists across all seasons and affects older children.
19. What historical red flags suggest an alternative diagnosis of primary ciliary dyskinesia in a child presenting with chronic wet cough and recurrent wheeze?A history of neonatal respiratory distress in a term infant, chronic daily wet cough from early infancy, chronic recurrent rhinosinusitis, and chronic otitis media with effusion.
20. What specific questions should be asked regarding socioeconomic and psychological factors that contribute to severe asthma exacerbations?Inquire about barriers to medication access, financial constraints limiting purchase of metered-dose inhalers or spacers, exposure to high psychosocial stress, and family anxiety levels during acute attacks.

Physical Examination & Bedside Signs

QuestionAnswer
1. How does assessing the speech capability of a child during a severe acute asthma attack reflect the degree of airflow obstruction?1. The ability to speak in full sentences, short phrases, or single words correlates directly with the work of breathing and severity of airway narrowing. 2. A child who can only utter single words or refuses to speak due to breathlessness indicates severe dynamic hyperinflation and imminent respiratory exhaustion.
2. What specific inspection findings characterize the use of accessory muscles of respiration in a pediatric patient with severe acute asthma?1. Noticeable contraction of the sternocleidomastoid and scalene muscles during inspiration, coupled with suprasternal, intercostal, and subcostal indrawing. 2. Tracheal tugging is prominently observed as the trachea is pulled inferiorly with each inspiratory effort due to severe negative intrathoracic pressure.
3. How do you properly inspect for paradoxical thoracoabdominal breathing, and what does it signify in an acute asthma exacerbation?1. Inspect the chest and abdomen simultaneously; paradoxical breathing is observed when the abdomen draws inward during inspiration while the ribcage expands or lags. 2. This ominous sign indicates extreme diaphragmatic fatigue and impending respiratory muscle failure.
4. What specific anthropometric parameters must be evaluated during the clinical examination of a child with chronic severe asthma?1. Accurate measurement of height, weight, and calculation of BMI percentiles to screen for corticosteroid-induced growth retardation or obesity, which heavily worsens asthma control. 2. Chest circumference and shape (barrel chest) should be noted as markers of long-term air trapping.
5. How is pulsus paradoxus clinically elicited at the bedside, and what pathophysiological mechanism causes it in severe asthma?1. Palpate the peripheral pulse while slowly deflating a sphygmomanometer cuff and note the exact pressure at which the pulse first disappears during inspiration versus expiration; a drop exceeding 10 to 15 mmHg constitutes pulsus paradoxus. 2. It is caused by exaggerated negative intrathoracic pressure swings and lung hyperinflation impeding left ventricular venous return and stroke volume.
6. How do you auscultate the chest to accurately determine the prolonged expiratory-to-inspiratory ratio in acute asthma?1. Listen systematically across all lung zones using the diaphragm of the stethoscope, paying close attention to the time duration of breath sounds. 2. In severe asthma, expiration is markedly prolonged, yielding an expiratory-to-inspiratory ratio of 1:3 or 1:4 compared to the normal 1:1 ratio.
7. What distinct auscultatory characteristics differentiate polyphonic wheezes from monophonic wheezes during bedside examination?1. Polyphonic wheezes consist of multiple musical pitches of varying tones occurring simultaneously, reflecting widespread, diffuse narrowing across multiple small airways typical of generalized asthma. 2. Monophonic wheezes present as a single pitch arising from a solitary, large airway obstruction such as a foreign body or localized endobronchial lesion.
8. How is the physical sign of a 'silent chest' elicited, and what is its critical clinical implication?1. Auscultation reveals near-total absence of breath sounds and wheezes across lung fields despite obvious respiratory distress and accessory muscle use. 2. It indicates critical airflow limitation with a forced expiratory volume in one second falling below 25 percent of predicted, representing an immediate threat of respiratory arrest.
9. How does the level of consciousness change during the clinical progression from a severe acute asthma attack to impending respiratory failure?1. Early in an exacerbation, children are often agitated, anxious, and restless due to hypoxia and hypercapnia. 2. As carbon dioxide narcosis sets in and exhaustion progresses, the child becomes increasingly lethargic, drowsy, and eventually comatose.
10. What specific bedside observation distinguishes cyanosis of respiratory origin from acrocyanosis in an acutely wheezing infant?1. Central cyanosis is manifested by a bluish discoloration of the tongue, lips, and oral mucosa, indicating severe arterial hypoxemia and inadequate pulmonary oxygenation. 2. Acrocyanosis is restricted to the hands and feet due to peripheral vasoconstriction and is not a direct marker of severe central respiratory failure.
11. How does palpation assist in evaluating the severity of a severe acute asthma exacerbation at the bedside?1. Palpation helps assess tactile fremitus, symmetrical chest wall expansion, and the presence of localized tenderness or crepitus if barotrauma (pneumothorax or pneumomediastinum) has occurred. 2. It also helps confirm tracheal position and detect generalized hyperinflation through reduced chest wall compliance.
12. What specific findings should be noted when examining the upper airway and nasal mucosa in an asthmatic child during a physical examination?1. Inspection of the nasal mucosa often reveals pale, edematous turbinates and clear watery secretions indicative of concomitant allergic rhinitis. 2. Examination should also screen for nasal polyps, which are frequently associated with severe aspirin-exacerbated respiratory disease or cystic fibrosis.
13. How is the measurement of peak expiratory flow rate (PEFR) integrated into the physical assessment of cooperative children over 5 years old?1. Using a peak flow meter, the child takes a deep breath and blows out as hard and fast as possible into the device; the best of three attempts is recorded. 2. Results are compared against the child's personal best or predicted normal values based on height, where a value below 50 percent indicates a severe exacerbation.
14. VIVA TRAP: Can the absence of audible wheezing on routine auscultation completely rule out an acute asthma exacerbation in a child presenting with respiratory distress?NO. Severe airflow limitation can cause a 'silent chest' where air movement is so diminished that wheezes are completely inaudible, representing a life-threatening emergency rather than a normal status.
15. How do you systematically evaluate chest wall deformities resulting from long-standing pediatric asthma during physical examination?1. Inspect for an increased anteroposterior diameter resulting in a barrel-shaped chest from chronic hyperinflation. 2. Assess for Harrison's sulcus (a horizontal groove along the lower border of the insertion of the diaphragm) and pectus carinatum resulting from chronic traction on compliant chest walls during early childhood.
16. How does the clinician evaluate peripheral perfusion and hydration status during the rapid triage physical examination of a severe acute asthma patient?1. Assess capillary refill time by pressing on the nail bed or sternum; a delayed refill exceeding 3 seconds indicates poor tissue perfusion and cardiovascular compromise. 2. Evaluate mucosal dryness and skin turgor to rule out dehydration resulting from tachypnea, increased insensible fluid loss, and poor oral intake during the acute illness.
17. What specific physical inspection finding indicates life-threatening diaphragmatic fatigue and imminent respiratory arrest in a child with a severe asthma exacerbation?Paradoxical thoracoabdominal breathing (where the abdomen moves inward during inspiration and outward during expiration due to severe exhaustion of the accessory and intercostal muscles) signals impending respiratory failure.
18. VIVA TRAP: Can the absence of an audible wheeze ("silent chest") during auscultation in an acutely distressed child be reliably interpreted as clinical improvement and resolution of bronchospasm?NO. A silent chest represents critical, near-total airflow obstruction where airflow is so severely reduced that wheezing cannot be generated, constituting an immediate life-threatening emergency requiring aggressive resuscitation.

Diagnostic Criteria & Investigations

QuestionAnswer
1. What is the gold standard diagnostic investigation for confirming airway reversibility in children older than 5 years suspected of having asthma outside of an acute setting?1. Spirometry demonstrating a post-bronchodilator increase in FEV1 of ≥12% from the baseline value. 2. Performed after withholding short-acting beta-2 agonists for at least 4 hours and long-acting bronchodilators appropriately.
2. According to GINA guidelines, what is the primary diagnostic modality in children under 5 years of age where formal spirometry is unachievable?1. Diagnosis is primarily clinical, based on a comprehensive pattern of recurrent respiratory symptoms like wheeze, cough, and shortness of breath. 2. Documented clinical improvement during a 2 to 3-month therapeutic trial of low-dose controller therapy (Inhaled Corticosteroids).
3. What is the validated 12-point clinical scoring tool recommended to objectively assess the severity of an acute asthma exacerbation in children in the emergency department?1. The Pediatric Respiratory Assessment Measure (PRAM). 2. It scores 5 items: suprasternal retractions, scalene muscle contraction, air entry, wheezing, and oxygen saturation, categorizing scores into mild (0–3), moderate (4–7), and severe (8–12).
4. VIVA TRAP: Is routine chest radiography mandatory in every child presenting with a first-time or severe acute asthma exacerbation?NO. Chest radiography is not routinely recommended for uncomplicated asthma exacerbations and should be reserved for cases with suspected focal consolidation, foreign body aspiration, pneumothorax, or lack of response to initial therapy.
5. What specific peripheral blood laboratory finding supports an atopic phenotype in a child being evaluated for chronic asthma?1. Peripheral blood eosinophilia with an absolute eosinophil count ≥400/µL or >4% of total leukocyte count. 2. Elevated total serum IgE and specific IgE levels against common aeroallergens via skin prick testing or ImmunoCAP.
6. What is the precise pulse oximetry cutoff that defines hypoxemia requiring immediate oxygen supplementation during an acute asthma exacerbation per current guidelines?1. Oxygen saturation (SpO2) <94% on room air at sea level. 2. Supplemental oxygen should be titrated rapidly to maintain target SpO2 between 94% and 98% in children.
7. What arterial blood gas (ABG) finding signifies impending respiratory failure and the urgent need for invasive or non-invasive mechanical ventilation in status asthmaticus?1. A normal or rising arterial carbon dioxide tension (PaCO2 >45 mmHg) in the setting of severe tachypnea and respiratory distress, reflecting muscle exhaustion and alveolar hypoventilation. 2. Accompanied by severe hypoxemia and uncompensated respiratory or mixed acidosis.
8. How does exhaled nitric oxide (FeNO) testing aid in the diagnostic workup of pediatric asthma?1. Elevated FeNO levels reflect Type 2 airway inflammation driven by eosinophils. 2. It helps support an allergic asthma phenotype and assesses adherence or responsiveness to corticosteroid therapy, though it is not diagnostic in isolation.
9. What diagnostic investigations are indicated when a child with suspected severe asthma fails standard therapy and has a history of recurrent pulmonary infections and failure to thrive?1. Sweat chloride test or genetic panel for Cystic Fibrosis transmembrane conductance regulator (CFTR) mutations. 2. Serum immunoglobulin profile (IgG, IgA, IgM, IgE) to rule out primary humoral immunodeficiencies.
10. What are the characteristic laboratory biomarker cutoffs for peripheral eosinophils and serum total IgE that classify severe uncontrolled asthma into Type 2 high inflammation?1. Peripheral blood eosinophils ≥150/µL and/or serum total IgE ≥30 IU/mL, which guide eligibility for specific biologic therapies like monoclonal antibodies (e.g., omalizumab, mepolizumab).
11. How does lung ultrasound play a role in the emergency assessment of a child presenting with severe acute respiratory distress and wheezing?1. Rapid bedside assessment to identify lung sliding, rule out pneumothorax (absence of lung sliding and presence of stratosphere sign on M-mode), and detect B-lines indicating alveolar-interstitial syndrome or pneumonia.
12. What differential diagnosis must be investigated via upper gastrointestinal investigations in a child with chronic nocturnal asthma symptoms unresponsive to high-dose ICS?1. Gastroesophageal reflux disease (GERD) or micro-aspiration, evaluated via 24-hour pH-impedance monitoring or upper GI endoscopy if structural anomalies are suspected.
13. What specific imaging or diagnostic test is mandatory if an acute wheezing presentation is localized unilaterally with decreased breath sounds on one side in a 2-year-old child?1. Rigid or flexible bronchoscopy, which serves as both the gold standard diagnostic and therapeutic modality for foreign body aspiration. 2. Expiratory chest X-ray or lateral decubitus view may show air trapping if bronchoscopy is delayed.
14. What is the clinical interpretation of a hypercapnic ABG with a pH of 7.15 in an asthmatic child who has been receiving aggressive continuous nebulized salbutamol?1. It signifies critical exhaustion, impending respiratory arrest, and the failure of pharmacological bronchodilator therapy alone. 2. Immediate preparation for non-invasive positive pressure ventilation (NIPPV) or endotracheal intubation with controlled mechanical ventilation is required.
15. What characteristic radiographic findings are typically observed on an emergency chest X-ray in a child with severe acute asthma, and when is this imaging strictly indicated?1. Chest X-ray typically reveals bilateral lung hyperinflation (flattened diaphragms, increased retrosternal clear space, and 10–11 posterior ribs visible) along with peribronchial cuffing.
2. Routine chest radiography is NOT recommended for uncomplicated acute asthma exacerbations.
3. It is strictly indicated only when suspecting alternative or complicating diagnoses such as pneumothorax, pneumomediastinum, focal lobar collapse, or foreign body aspiration.
16. VIVA TRAP: Can peak expiratory flow rate (PEFR) measurement via a handheld peak flow meter be reliably performed and interpreted in a young child presenting with severe acute respiratory distress in the emergency department?NO. Peak expiratory flow rate measurement requires active, maximal, and reproducible forced expiratory technique, which is unreliable and generally impossible to perform accurately in young children (<5–6 years of age) or in any child experiencing severe acute respiratory distress.

Evidence-Based Management & Pharmacotherapy

QuestionAnswer
1. What is the standard pediatric dosing regimen for short-acting beta-2 agonist (Salbutamol) nebulization in severe acute asthma?Salbutamol is administered at 0.15 mg/kg (minimum 2.5 mg, maximum 5 mg) via nebulization every 20 minutes for the first hour or continuously for severe distress.
2. How does the mechanism of action of Ipratropium Bromide complement Salbutamol in acute severe asthma?Ipratropium is an inhaled anticholinergic (antimuscarinic) that blocks vagally mediated reflex bronchoconstriction and reduces mucous secretion, providing synergistic bronchodilation when combined with a SABA.
3. What is the recommended oral systemic corticosteroid dosage and duration for a child experiencing a moderate-to-severe acute asthma exacerbation?Oral Prednisolone is given at 1 to 2 mg/kg/day (maximum 40–50 mg/day) as a single daily dose for a total duration of 3 to 5 days without requiring a taper.
4. When is intravenous Magnesium Sulfate indicated in the acute pharmacotherapy of severe pediatric asthma, and what is its dose?Indicated for severe exacerbations failing initial intensive bronchodilator and steroid therapy; dosed at 40 to 50 mg/kg (maximum 2 grams) infused intravenously over 20 minutes.
5. What is the primary mechanism of action of intravenous Magnesium Sulfate as an adjunct in status asthmaticus?It acts as a non-competitive calcium channel blocker and physiological antagonist, causing relaxation of bronchial smooth muscle and inhibiting histamine release from mast cells.
6. What are the key clinical monitoring parameters required during the intravenous infusion of Magnesium Sulfate in an emergency setting?Continuous monitoring of blood pressure (for hypotension), heart rate, respiratory rate, and patellar deep tendon reflexes (loss of reflexes indicates early hypermagnesemia toxicity).
7. What is the second-line continuous infusion bronchodilator option used in children with life-threatening status asthmaticus refractory to nebulized SABA?Intravenous Salbutamol infusion initiated at a loading dose of 15 mcg/kg over 10–15 minutes, followed by a continuous maintenance infusion ranging from 1 to 5 mcg/kg/minute, titrated upward.
8. What are the major toxicities and side effects that must be actively monitored during continuous intravenous Salbutamol infusions?Tachycardia, tachyarrhythmias (supraventricular tachycardia), myocardial ischemia, hypokalemia due to intracellular potassium shift, and hyperglycemia.
9. What is the GINA-recommended approach for reliever therapy in older children (≥6 years) utilizing the SMART track?The Single Maintenance and Reliever Therapy (SMART) track uses low-dose ICS-Formoterol as both the daily controller and the as-needed reliever medication.
10. What is the pharmacological rationale for choosing Formoterol over Salbutamol in a combined ICS-Formoterol reliever regimen?Formoterol provides a rapid onset of action comparable to Salbutamol (within 1–3 minutes) while simultaneously delivering an anti-inflammatory dose of ICS directly to the newly constricted airways.
11. What is the correct technique for administering aerosolized medications via Metered-Dose Inhaler (MDI) to a toddler in acute distress?Use an appropriately sized valved holding chamber (spacer) with a tight-fitting facial mask, actuating one puff at a time followed by 5 to 6 tidal breaths.
12. What essential post-inhalation instruction must be given to older children receiving inhaled corticosteroids to prevent local adverse effects?Thorough mouth rinsing and gargling with water followed by spitting out (not swallowing) to prevent oral candidiasis (thrush) and dysphonia.
13. What are the primary surgical or procedural indications for initiating invasive mechanical ventilation in a child with severe status asthmaticus?Exhaustion, altered mental status, recurrent apnea, severe refractory respiratory acidosis (pH <7.15 with rising PaCO₂), and complete cardiovascular collapse.
14. What specific ventilator management strategy (Permissive Hypercapnia) is employed when mechanically ventilating a child with severe asthma?Using low respiratory rates, longer expiratory times (low I:E ratio), and lower tidal volumes to prevent dynamic hyperinflation (auto-PEEP) and barotrauma, accepting elevated PaCO₂.
15. VIVA TRAP: Can systemic corticosteroids be abruptly stopped after a 5-day course for an acute asthma exacerbation in a child without a tapering schedule?YES. Short courses of systemic corticosteroids (3 to 5 days) for acute exacerbations do not suppress the hypothalamic-pituitary-adrenal axis sufficiently to require tapering.
16. What is the recommended duration of step-down surveillance and follow-up after discharging a child hospitalized for severe acute asthma?Clinical reassessment and inhaler technique check within 2 to 7 days post-discharge, with a comprehensive review of the written asthma action plan.
17. What is the role and dosing of Aminophylline or Theophylline in the modern emergency management of severe pediatric acute asthma per current guidelines?NONE. Routine use of Aminophylline/Theophylline is no longer recommended in modern pediatric guidelines due to a narrow therapeutic index and high toxicity profile compared to safer adjuncts like Magnesium Sulfate.

High-Yield VIVA TRAPs & Examiner Pitfalls

QuestionAnswer
1. VIVA TRAP: Can short-acting sedatives such as diazepam or midazolam be administered safely to a severely agitated, struggling child in status asthmaticus?NEVER. Sedatives and anxiolytics depress the respiratory center, suppress the protective cough reflex, and rapidly precipitate fatal respiratory arrest.
2. VIVA TRAP: Should epinephrine (adrenaline) be administered subcutaneously or intramuscularly as a first-line rescue drug for uncomplicated severe acute asthma?NO. Epinephrine is not indicated for routine asthma management and is strictly reserved for concurrent anaphylaxis or acute severe asthma refractory to standard maximal inhaled therapies.
3. VIVA TRAP: Is escalating doses of continuous nebulized Salbutamol completely safe without monitoring biochemical parameters in the acute resuscitation bay?NO. High-dose continuous beta-2 agonism causes significant intracellular potassium shifts leading to profound hypokalemia, as well as hyperglycemia and dangerous tachyarrhythmias.
4. VIVA TRAP: Can cromones (such as sodium cromoglycate) or nedocromil be utilized as rapid-acting rescue bronchodilators in an acute severe asthma emergency?NEVER. Cromones are obsolete non-bronchodilating anti-inflammatory agents that have zero role in reversing acute bronchospasm.
5. VIVA TRAP: Should humidified oxygen via tight-fitting face masks be withheld if a child with severe asthma develops mild carbon dioxide retention?NO. Hypoxemia is life-threatening and must always be aggressively corrected first with titrated oxygen; controlled oxygen delivery should be utilized, but hypoxemia must never be ignored.
6. VIVA TRAP: Can heliox (helium-oxygen mixture) therapy replace mechanical ventilation when a child develops a silent chest and hypercapnic encephalopathy?NO. While heliox reduces gas turbulence and work of breathing in moderate-to-severe obstruction, it cannot reverse impending respiratory arrest and must not delay intubation when clinical exhaustion sets in.
7. VIVA TRAP: Is subcutaneous terbutaline or intravenous aminophylline recommended as first-line rescue therapy for children presenting with severe acute asthma in modern emergency protocols?NEVER. Aminophylline has a very narrow therapeutic index, high toxicity (arrhythmias, seizures), and has been superseded by safer, highly effective beta-2 agonists and adjuncts like magnesium sulfate.
8. VIVA TRAP: Can metered-dose inhalers (MDIs) with valved holding chambers be safely abandoned in favor of nebulizers when a child is in severe respiratory distress?NO. Clinical trials demonstrate that an MDI with a proper spacer and mask is at least as effective as nebulization, delivers medication faster, and causes fewer systemic side effects.
9. VIVA TRAP: Can long-acting beta-2 agonists (LABAs) like Formoterol or Salmeterol be used as monotherapy rescue relievers during an acute severe asthma attack outside of an ICS-Formoterol MART protocol?NEVER. Using LABAs as monotherapy without an inhaled corticosteroid drastically increases the risk of severe, life-threatening exacerbations and asthma-related mortality.
10. VIVA TRAP: Is it appropriate to discharge a child from the emergency department immediately after a single dose of nebulized SABA and systemic steroids if their wheeze disappears?NO. Children require a mandatory observation period of at least 2 to 4 hours post-treatment to ensure sustained clinical stability and prevent "rebound" bronchospasm before safe discharge.
11. VIVA TRAP: Should chest tube insertion be performed immediately if a child with severe asthma is noted to have hyperresonant lung fields and decreased breath sounds?NO. Hyperresonance and muffled breath sounds reflect severe air trapping and hyperinflation in asthma, not a tension pneumothorax, unless a definitive pleural line or mediastinal shift is imaged.
12. VIVA TRAP: Can systemic corticosteroid therapy be safely omitted in a child admitted to the PICU for status asthmaticus if their symptoms improve dramatically within 30 minutes of initial SABA?NO. Systemic corticosteroids take several hours to exert their anti-inflammatory effects and prevent late-phase inflammatory rebound; they must be given promptly regardless of initial acute bronchodilator response.
13. VIVA TRAP: Is it safe to allow a child recovering from severe acute asthma to immediately resume vigorous physical sports and outdoor exercise upon discharge?NEVER. Airway hyper-responsiveness persists for days to weeks following an acute exacerbation; physical exertion should be restricted until clinical recovery and baseline pulmonary function are restored.
14. VIVA TRAP: Can routine use of expectorant cough syrups containing antihistamines or codeine be prescribed to suppress nighttime coughing in an acute asthmatic child?NEVER. Antihistamines dry up airway secretions and thicken mucus plugs, while codeine and opioid derivatives suppress the respiratory drive and cough reflex, leading to catastrophic asphyxiation.
15. VIVA TRAP: Can chest physiotherapy and postural drainage be prescribed aggressively to help clear thick mucus plugs in a child currently experiencing a severe acute asthma attack?NEVER. Chest physiotherapy and postural drainage are strictly contraindicated during an acute severe asthma exacerbation because they increase patient anxiety, exacerbate bronchospasm, increase oxygen consumption, and fail to mobilize lower airway mucus plugs.
16. VIVA TRAP: Can broad-spectrum systemic antibiotic therapy be routinely initiated alongside bronchodilators and steroids for every child admitted to the hospital with a severe acute asthma exacerbation?NEVER. Antibiotics must not be prescribed routinely, as the vast majority of acute asthma exacerbations are triggered by viral infections rather than bacterial pathogens; antibiotics are indicated only if there is objective, confirmed evidence of a secondary bacterial infection such as focal lobar consolidation or acute otitis media.
17. VIVA TRAP: Is it safe to perform routine arterial blood gas (ABG) punctures on every pediatric patient presenting with moderate-to-severe acute asthma to monitor oxygenation status?NO. Routine arterial punctures are extremely painful, induce severe distress and crying which drastically worsens ventilation-perfusion mismatch and hypoxemia, and are entirely unnecessary; non-invasive continuous pulse oximetry provides adequate assessment of oxygenation, while capillary blood gases or venous blood gases are sufficient for assessing pH and PCO2 when clinically indicated.